Platinum Equity acquires Owens & Minor

Platinum Equity has finalized its acquisition of Owens & Minor's Products & Healthcare Services (P&HS) unit, forming a new privately held entity. While the financial details of the transaction have not been made public, the move positions Owens & Minor P&HS as a standalone company under Platinum Equity’s portfolio. The acquisition underscores the continued interest in enhancing medical supply chains, particularly in the acute care market where Owens & Minor plays a significant role.

Owens & Minor P&HS, based in Richmond, Virginia, operates a comprehensive medical supply distribution network serving hospitals and healthcare providers across the United States. Notably, Owens & Minor retains a 5% stake in the business. Concurrently, Owens & Minor's remaining operations are set to be rebranded as Accendra Health, Inc., by December 31, 2025. This transaction involved multiple financial and legal advisors, including Bank of America, Citi, and Kirkland & Ellis, underpinning its complexity and impact.

The strategic rationale behind this acquisition aligns with Platinum Equity’s focus on acquiring and enhancing businesses. For over 140 years, Owens & Minor has established a reputation for customer-focused service. Now, with Platinum Equity's backing, the goal is to leverage its operational expertise to strengthen the company’s supply chain, improve efficiency, and expand proprietary product offerings. Platinum Equity Co-President Jacob Kotzubei emphasized the firm’s intention to support the business's evolution into a more agile and responsive healthcare partner.

This acquisition occurs within a broader sector backdrop where consolidation and efficiency enhancement remain primary themes. The healthcare distribution landscape is particularly competitive, with players under pressure to streamline operations and meet rising demand from healthcare providers. By acquiring Owens & Minor P&HS, Platinum Equity seeks to capitalize on scale and integration benefits that can offer a competitive edge in meeting modern healthcare needs.

Looking ahead, the success of this transition will largely depend on the ability to integrate operational improvements without disrupting service levels. Attention will also be on how effectively Platinum Equity can execute supply chain enhancements and drive growth in proprietary offerings. Stakeholders and market observers will be keen to gauge the operational changes and performance outcomes as the newly independent entity embeds within the Platinum Equity portfolio.